| Active substance |
Peptide |
| Also known as |
CJC-1295 without DAC, Sermorelin |
| Blood pressure |
Minimal or no impact on blood pressure |
| Chemical name |
Modified GRF (1-29), tetrasubstituted GRF (1-29) |
| Dosage (medical) |
Typically 100 micrograms per injection, administered 1-3 times daily |
| Dosage (sports) |
100-300 micrograms per injection, 1-3 times daily |
| Effects |
Increased muscle mass, reduced body fat, improved recovery and sleep |
| Formula |
C152H252N44O42 |
| Half-life |
Approximately 30 minutes |
| Hepatotoxicity |
None |
| Lab Test |
Growth hormone levels can be measured |
| Main action |
Increases growth hormone secretion |
| Side effects |
Pain at injection site, itching, possible gynecomastia, increased water retention |
| Storage conditions |
Store in a refrigerator, avoid freezing |
| Substance class |
Peptide hormone |
| Trade name |
CJC-1295 without DAC |
| Use in sports |
Commonly used for performance enhancement, muscle growth, and recovery |
| Water Retention |
Moderate |
| Active ingredient, mg |
5 |
| Release form |
Vial |
| 1 Ampoule, ml |
10 |
| Vials in the package, pcs |
1 |
| Manufacturer |
Peptide Sciences |
